Entrada Therapeutics is a clinical-stage biopharmaceutical company focused on developing a new class of medicines for intracellular targets. The company is advancing a portfolio of genetic medicines for neuromuscular and inherited retinal diseases. Entrada has a catalyst-rich period approaching, with multiple clinical data readouts expected by 2026 for its Duchenne muscular dystrophy (DMD) programs and its collaboration with Vertex Pharmaceuticals for myotonic dystrophy type 1 (DM1). Entrada is seeking to grow its team with dedicated individuals who are ready to make a significant impact on patients' lives.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Part-time
Career Level
Senior
Education Level
Ph.D. or professional degree